Vellykket fase 3-studie i Kina bekræfter sikkerhed og effekt af ACARIZAX® hos patienter med husstøvmideallergi

Intern viden

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.